{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T07:51:15Z","timestamp":1771055475315,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jsat.2021.108282","type":"journal-article","created":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T18:49:14Z","timestamp":1610131754000},"page":"108282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries"],"prefix":"10.1016","volume":"124","author":[{"given":"Yong-Fang","family":"Kuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukaila A.","family":"Raji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1_suppl","key":"10.1016\/j.jsat.2021.108282_bb0005","doi-asserted-by":"crossref","first-page":"100S","DOI":"10.1177\/0033354920922975","article-title":"A rapid review of the impact of systems-level policies and interventions on population-level outcomes related to the opioid epidemic, United States and Canada, 2014\u20132018","volume":"135","author":"Ansari","year":"2020","journal-title":"Public Health Reports"},{"key":"10.1016\/j.jsat.2021.108282_bb0010","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2021.108282_bb0015","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40621-017-0118-7","article-title":"Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis","volume":"4","author":"Brady","year":"2017","journal-title":"Injury Epidemiology"},{"key":"10.1016\/j.jsat.2021.108282_bb0020","series-title":"NLM Matter\u00ae Number:SE1604","article-title":"Medicare coverage of substance abuse services","author":"Center for Medicare and Medicaid Services","year":"2019"},{"key":"10.1016\/j.jsat.2021.108282_bb0025","author":"Center for Medicare and Medicaid Services"},{"key":"10.1016\/j.jsat.2021.108282_bb0030","unstructured":"Centers for Disease Control and Prevention. The tree waves of opioid overdose deaths. Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html. Accessed September 23, 2020."},{"key":"10.1016\/j.jsat.2021.108282_bb0035","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.jsat.2021.108282_bb0040","author":"Centers for Medicare & Medicaid Services"},{"key":"10.1016\/j.jsat.2021.108282_bb0045","series-title":"National drug threat assessment. DEA-DCT-DIR-007-20","author":"Drug Enforcement Administration","year":"2019"},{"key":"10.1016\/j.jsat.2021.108282_bb0050","author":"Health Data"},{"key":"10.1016\/j.jsat.2021.108282_bb0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.08.026","article-title":"Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III","volume":"156","author":"Kerridge","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"11","key":"10.1016\/j.jsat.2021.108282_bb0060","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15638","article-title":"Association of disability with mortality from opioid overdose among US Medicare adults","volume":"2","author":"Kuo","year":"2019","journal-title":"JAMA Network Open"},{"issue":"5","key":"10.1016\/j.jsat.2021.108282_bb0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/jgs.15332","article-title":"Opioid prescriptions in older Medicare beneficiaries after the 2014 federal rescheduling of hydrocodone products","volume":"66","author":"Kuo","year":"2018","journal-title":"Journal of American Geriatrics Society"},{"issue":"4","key":"10.1016\/j.jsat.2021.108282_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060600","article-title":"Characteristics of opioid-users whose death was related to opioid-toxicity: A population-based study in Ontario, Canada","volume":"8","author":"Madadi","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jsat.2021.108282_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/1468-0009.12436","article-title":"The association of state opioid misuse prevention policies with patient- and provider-related outcomes: A scoping review","volume":"98","author":"Mauri","year":"2020","journal-title":"Milbank Quarterly"},{"key":"10.1016\/j.jsat.2021.108282_bb0080","first-page":"1","article-title":"Gender differences in diversion among non-medical users of prescription opioids and sedatives","author":"Milani","year":"2020","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108282_bb0085","series-title":"Illicit supply of fentanyl and other synthetic opioid \u2013 Transitioning market evolving challenges","author":"Pardo","year":"2019"},{"key":"10.1016\/j.jsat.2021.108282_bb0090","first-page":"1","article-title":"Sources of misused prescription opioids and their association with prescription opioid use disorder in the United States: Sex and age differences","author":"Park","year":"2020","journal-title":"Substance Use and Misuse"},{"issue":"2","key":"10.1016\/j.jsat.2021.108282_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1377\/hlthaff.2018.05232","article-title":"A transitioning epidemic: How the opioid crisis is driving the rise in hepatitis C","volume":"38","author":"Powell","year":"2019","journal-title":"Health Affairs"},{"key":"10.1016\/j.jsat.2021.108282_bb0100","series-title":"Fentanyl","author":"Ramos-Matos","year":"2020"},{"issue":"5152","key":"10.1016\/j.jsat.2021.108282_bb0105","first-page":"1419","article-title":"Drug and opioid-involved overdose deaths \u2014 United States, 2013\u20132017","volume":"67","author":"Scholl","year":"2019","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1","key":"10.1016\/j.jsat.2021.108282_bb0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/jamainternmed.2017.7280","article-title":"Association of household opioid availability and prescription opioid initiation among household members","volume":"178","author":"Seamans","year":"2018","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.jsat.2021.108282_bb0115","series-title":"Opioid use in Medicare part D remains concerning. HHS OIG Data Brief. OEI-18-00220","author":"U.S. Department of Health and Human Services","year":"2018"},{"issue":"2B","key":"10.1016\/j.jsat.2021.108282_bb0120","article-title":"Fentanyl is superior to morphine \u2013 Fact of myth \u2026 revisited","volume":"4","author":"Wells","year":"2004","journal-title":"Formulary Flash"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221000088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:53:05Z","timestamp":1760039585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221000088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":24,"alternative-id":["S0740547221000088"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108282","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overdose deaths from nonprescribed prescription opioids, heroin, and other synthetic opioids in Medicare beneficiaries","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108282","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108282"}}